Close Menu

DNA capture

These hybrid capture-based methods target gene transcripts of interest, which could shrink sequencing costs for some experiments by as much as 90 percent.

The US Court of Appeals for the Federal Circuit sent the case, which had been thrown out in December 2018, back to the trial court.

The Stanford University spinout claims it can get three times the nucleic acid yield as column- or magnetic bead-based methods, with less damage to the molecules.

BGI is planning to offer free trials of its MGI DNBSEQ-G400 sequencing system to key opinion leaders, a development Illumina is trying to stop.

The companies will incorporate PerkinElmer's LabChip GX Touch nucleic acid analyzer in the upfront workflow of Agena's MassArray system.

Roche said the layoffs at its Madison, Wisconsin site will start Dec. 31 and continue through June 30, 2020.

Researchers demonstrated the feasibility of finding multiple myeloma mutations with a new circulating tumor DNA sequencing method known as LB-Seq. 

The new platform will be a stripped-down version of the firm's Geniom RT Analyzer, lacking a camera. It will cost under $100,000 and initially be launched for use with the Applied Biosystems SOLiD platform.

The deal is part of a strategic co-marketing agreement between Febit and Life Technologies, under which Febit has become a member of Life Tech's service provider programs for SOLiD and TaqMan.

The method, called primer extension capture, or PEC, is especially suited for capturing short DNA fragments in order to sequence a few small genomic regions in large numbers of individuals. Originally developed to analyze areas of interest in the Neandertal nuclear genome, it might also be useful for other types of targeted sequencing applications.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.